Valneva SE (INRLF)
Makes vaccines for diseases like Japanese encephalitis, cholera, and Lyme disease
$2.77+0.06%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-31.6%
The outlook
Valneva is trading near its 52-week low, well below its moving averages, signaling weakness in the near term. Analyst coverage is sparse, and the overall sentiment leans bearish. The stock's position near the bottom of its yearly range suggests investors remain cautious.
What’s behind the score
Price trendMixed vs its moving averages
52-week range8% of the way from its 52-week low to high
Market cap
$565.7M
52-wk high
$6.28
52-wk low
$2.46
50-day avg
$2.61
200-day avg
$3.85
Trailing P/E
—